How did the introduction of the measles-containing vaccine second dose (MCV2) affect measles vaccine uptake? – evidence from Nigeria [PDF]
Human Vaccines & ImmunotherapeuticsNigeria has the highest burden of measles worldwide, as measles vaccine uptake remains low. Recently, the second dose of the measles-containing vaccine (MCV2) was introduced as part of the routine immunization (RI) program, and this study examined how it
Ryoko Sato
doaj +2 more sources
Predictors for low coverage of uptake of second dose of measles vaccine among children in sub-Saharan Africa, 2023: a systematic review and meta-analysis [PDF]
Journal of Pharmaceutical Policy and PracticeBackground Measles became a public health important disease in sub-Saharan Africa. World Health Organization recommended measles-containing vaccine dose 2 (MCV2) through routine service delivery.
Tamirat Melis +5 more
doaj +2 more sources
Cross-sectional Survey on Parental Perception and Attitude on Measles Vaccine: Low Hospital Measles Case Presentation in Rural Area in Enugu, Nigeria [PDF]
Journal of Clinical and Diagnostic Research, 2021 Introduction: The incidence of measles has spiked in recent times despite the efforts to its eradication using a highly effective measles vaccine. Vaccine coverage and underreporting of cases are the major challenges to this effort.
Chukwuemeka Chijoke Nwangwu +2 more
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2022 Nigeria has one of the highest measles burdens in the world. While measles-containing vaccine is proven to be effective in reducing measles cases, empirical studies on the correlation between measles incidence and measles vaccine coverage in Nigeria has ...
Ryoko Sato +3 more
doaj +1 more source
Shanghai yufang yixue, 2022 Measles is an acute respiratory infectious disease caused by the measles virus. It is highly infectious and easy to occur in children. It causes many serious complications such as tracheitis， otitis media and pneumonia. Since the promotion of the measles
SHEN Jinhua +4 more
doaj +1 more source
Molecular Therapy: Oncolytics, 2016 To target oncolytic measles viruses (MV) to tumors, we exploit the binding specificity of designed ankyrin repeat proteins (DARPins). These DARPin-MVs have high tumor selectivity while maintaining excellent oncolytic potency.
Jan RH Hanauer +15 more
doaj +1 more source
Evaluation of a measles vaccine campaign by oral-fluid surveys in a rural Kenyan district: interpretation of antibody prevalence data using mixture models [PDF]
, 2009 We evaluated the effectiveness of a measles vaccine campaign in rural Kenya, based on oral-fluid surveys and mixture-modelling analysis. Specimens were collected from 886 children aged 9 months to 14 years pre-campaign and from a comparison sample of 598
E. O. OHUMA +13 more
core +1 more source
Molecular Therapy: Oncolytics, 2019 Measles virus (MeV) is naturally cytolytic by extensive cell-to-cell fusion. Vaccine-derived MeV is toxic for cancer cells and is clinically tested as oncolytic virus.
Jan R.H. Hanauer +3 more
doaj +1 more source
Safety of measles-containing vaccines in post-marketing surveillance in Anhui, China. [PDF]
PLoS ONE, 2017 The safety of measles vaccination is of great interest and importance to public health practice and the general society. We have analyzed the adverse events following immunization (AEFIs) of currently used measles-containing vaccines (including live ...
Fan-Ya Meng +7 more
doaj +1 more source
Seroepidemiology of measles in Addis Ababa Ethiopia: implications for control through vaccination [PDF]
, 2003 We undertook a representative survey of measles antibodies in Addis Ababa, Ethiopia 1994, to characterize immunity and transmission. Specific-antibody levels (IU/l) were determined by ELISA for 4654 sera from individuals aged 0–49 years (1805
Abebe, A. +6 more
core +2 more sources